MADISON (WLUK) -Whes Conditions could receive up to $ 12 million in accordance with the proposed agreement with eight opioid manufacturers.
Attorney General Josh Kaul announced the news on Monday. He and other 45 other lawyers plan to sign a contract with a manufacturer who can secure about $ 7.2 million nationwide for alleged manufacturers of the US opioid crisis.
KAUL said in a press release, “Effectively solving opioid infectious diseases brings resources.”
This agreement is not yet confirmed. The next step in this process is a signing period for local governments across the country.
Under the proposed contract, eight opioid companies pay the following amount.
- MyLan (currently part of Viaatris): $ 284,447,916 for 9 years
- HIKMA: $ 95,818,293 for 1-4 years
- Yangmu: $ 71,751,010 for 10 years
- Apotex: $ 63,682,369 in 1 year
- Indivior: $ 38,022,450 for 4 years
- Sun: $ 30,992,087 for 1-4 years
- ALVOGEN: $ 18,680,162 in 1 year
- Zydus: $ 14,859,220 a year
In addition to these reductions, some agreements will be allowed to receive free pharmaceutical products or cash instead of this product.
All companies that do not contain indivior can not create or sell opioid products including opioid promotion or marketing, or more than 40 mg of oxycodone per pill, and must implement monitoring and reporting systems for suspicious orders.
INDIVIOR has agreed not to manufacture or sell Opioid products for the next 10 years. However, you can continue marketing and drug sales to treat opioid disorders.
The proposed resolutions with these proposed contracts and the recently announced resolutions with Purdue Phara, Sackler Family, Wisconsin, and local governments have secured more than $ 880 million settlement as a company and individual funds that have helped to fuel to Opioid Revival.
